Cargando…
Next-generation antipsychotics- Trends and perspectives beyond dopaminergic and glutamatergic agents
INTRODUCTION: Three generations of antipsychotics, all of which are based on the dopaminergic hypothesis of schizophrenia, are available for clinical use. Still, more than 66% of the patients diagnosed with schizophrenia spectrum disorders (SSD) could not achieve remission. Also, the glutamatergic h...
Autores principales: | Vasiliu, O., Mangalagiu, A. G., Petrescu, B. M., Candea, C. A., Tudor, C., Ungureanu, D., Miclos, M., Florescu, C., Draghici, A. I., Bratu-Bizic, R. E., Dobre, M., Fainarea, A. F., Patrascu, M. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411408/ http://dx.doi.org/10.1192/j.eurpsy.2023.1177 |
Ejemplares similares
-
Mindfulness-based cognitive therapy for major depressive disorder- a literature review
por: Vasile, D., et al.
Publicado: (2021) -
T48. ANTIPSYCHOTIC EFFICACY OF EVENAMIDE (NW-3509) IS DUE TO MODULATION OF GLUTAMATERGIC DYSREGULATION
por: Anand, Ravi, et al.
Publicado: (2018) -
Ascorbic Acid Inhibits Development of Tolerance and Dependence to Opiates in Mice: Possible Glutamatergic or Dopaminergic Modulation
por: Kulkarni, S. K., et al.
Publicado: (2008) -
Neuroimaging glutamatergic mechanisms differentiating antipsychotic treatment-response
por: Mouchlianitis, Elias D., et al.
Publicado: (2023) -
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
por: Gasiorowska, Anna, et al.
Publicado: (2021)